ArticleEvidence-based complementary and alternative medicine : eCAM2011
Description of a sulfitobacter strain and its extracellular cyclodipeptides.
Article in Evidence-based complementary and alternative medicine : eCAM, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Stronger together: harnessing natural algal communities as potential probiotics for inhibition of aquaculture pathogens.Microbiology spectrum · 2025Article
- The core microbiome of cultured Pacific oyster spat is affected by age but not mortality.Microbiology spectrum · 2024Article
- Article
- Article
- Complete Genome of Marine Microalgae Associated Algicidal Bacterium Sulfitobacter pseudonitzschiae H46 with Quorum Sensing System.Current microbiology · 2021Article
- Ancient Bacterial ClassInternational journal of molecular sciences · 2021Article
- The Alteration of Intestinal Microbiota Profile and Immune Response inLife (Basel, Switzerland) · 2021Article
- From lithotroph- to organotroph-dominant: directional shift of microbial community in sulphidic tailings during phytostabilization.Scientific reports · 2015Article
- Cyclic dipeptides from rhabditid entomopathogenic nematode-associated Bacillus cereus have antimicrobial activities.World journal of microbiology & biotechnology · 2014Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A marine bacterium M44 was separated from 30 m deep seawater in the East China Sea (26° 28.3' N 122° 29.0' E) in 2006. 16S rDNA gene sequence comparison showed that the strain M44 was a member of the genus Sulfitobacter and highly similar to KMM 3554(T). A series of experiments demonstrated that this strain M44 had many distinctive characteristics: its cells were gram-negative and mesophilic; its colonies were slightly yellowish, round, convex, and smooth; and it could grow at 10-28°C, pH 6.0-10.0, and in the presence of 0-12.5% (w/v) NaCl; the optimum growth conditions were 25°C and pH 7.0, and the optimum Na(+) concentration was 2.5%. In addition, strain M44 contained 18 : 1 ω7c, 11 methyl 18 : 1 ω7c and 16 : 0 fatty acids as major fatty acids, and the genomic DNA G+C content was 58.04 mol%. According to our results of the secondary metabolites, six cyclodipeptides were isolated from the strain M44, which were Cyclo (Val-Leu), Cyclo (Phe-Val), Cyclo (Phe-Leu), Cyclo (Leu-Ile), Cyclo (Phe-Ile), and Cyclo (Trp-Pro). It is the first study of secondary metabolites isolated from this genus.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.